Latest News about European Medicines Agency

Recent news which mentions European Medicines Agency

< Previous 1 2 Next >

Why Novavax Shares Are Plunging Today Despite Much Awaited FDA Emergency Nod?

July 14, 2022

European Regulator Approves AstraZeneca's COVID-19 shot As Booster

May 23, 2022

EMA's CHMP Recommends AbbVie's Upadacitinib For Ulcerative Colitis

May 23, 2022

Calliditas' Kinpeygo Receives CHMP Backing For Kidney Disease

May 19, 2022

Here's Why This Analyst Is On Sidelines Despite European Approval Of Myovant's Relugolix For Prostate Cancer

May 02, 2022

Horizon Therapeutics' Inebilizumab Scores European Approval For Spinal Cord Inflammation

May 02, 2022

Myovant Sciences' Relugolix For Hormone-Sensitive Prostate Cancer Approved In Europe

May 02, 2022

Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall

April 25, 2022

EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs

April 22, 2022

EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting

April 22, 2022

Amryt Shares Trading Higher As EMA Endorses Approval Of Filsuvez In Genetic Skin Disease

April 22, 2022

Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer

April 13, 2022

Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation

April 07, 2022

Bristol Myers' Breyanzi Immunotherapy Approved In Europe For Lymphoma Indications

April 05, 2022

Bristol Myers Squibb Scores Three Back To Back European Approvals For Opdivo In Esophageal, Urothelial Cancer

April 05, 2022

Immunocore Eye Cancer Cell Therapy Scores European Approval

April 04, 2022

EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine

March 30, 2022

Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD

March 25, 2022

EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer

March 25, 2022

EMA's CHMP Clears Janssen, Legend's Multiple Myeloma CAR-T Therapy

March 25, 2022

EMA's Advisory Group Backs Approval For Merck's Keytruda In Various Cancer Settings

March 25, 2022

EMA Recommends Approval Of AstraZeneca's COVID-19 Therapy, Evusheld

March 24, 2022

Calliditas Expects EMA's CHMP Opinion For Nefecon In Q2

March 22, 2022

JAK Inhibitors Come Under EMA Scrutiny On Safety Concerns: All You Need To Know

February 14, 2022

Menstrual Irregularities Cases After mRNA COVID-19 Vaccine - EMA Reviews Cases

February 11, 2022

Why Are ObsEva Shares Trading Higher Today?

December 17, 2021

EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer

December 17, 2021

EMA Might Not Decide On Merck's COVID-91 Oral Antiviral Before Christmas: Reuters

December 17, 2021

Why Are Intercept Pharmaceuticals Shares Falling Today?

December 09, 2021

Europe's CHMP Backs Pfizer/BioNTech's COVID-19 Shot For Kids Aged 5-11 Years

November 26, 2021

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.